RIBio-Info

Home > DB > 동향

동향 내용
Hemostatic efficacy, safety and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease.
분류	pharmacokinetics	조회	2253
발행년도	2015	등록일	2015-10-17
출처	Blood (바로가기)

[추천 메일 발송]

리스트 이전글과 다음글
이전글	Pharmacokinetics of serelaxin in patients with severe renal impairment or end-stage renal disease requiring hemodialysis: A single-dose, open-label, parallel-group study.
다음글	Impact of Cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole.